4.7 Letter

Fasting conditions in clinical oncology trials and drug labelling

Journal

LANCET ONCOLOGY
Volume 18, Issue 9, Pages E506-E506

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(17)30585-5

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available